Flecainide CR

flecainide · MEDA Pharma GmbH & Co. KG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Flecainide CR, covering 2022-02-07 to 2022-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation. [Phase 4]